Preparation and in vitro-in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles

Journal of Microencapsulation

Volumn 27, Issue 1, 2010, Pages 25-36

  Glowka, Eliza ^a,b   Sapin Minet, Anne ^a   Leroy, Pierre ^a   Lulek, Janina ^b   Maincent, Philippe ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Bioavailability; Nanoparticles; Peptide stability; Salmon calcitonin; Sustained release

Indexed keywords

ACETIC ACID; NANOPARTICLE; POLYGLACTIN; SALCATONIN; ACRYLIC ACID RESIN; BONE DENSITY CONSERVATION AGENT; CALCITONIN; DELAYED RELEASE FORMULATION; EUDRAGIT RS; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG RELEASE; DRUG SYNTHESIS; EMULSION; EVAPORATION; IN VITRO STUDY; IN VIVO STUDY; NANOENCAPSULATION; NONHUMAN; POLYMERIZATION; RAT; WISTAR RAT; ANIMAL; BLOOD; CHEMISTRY; DELAYED RELEASE FORMULATION; MALE; PROTEIN STABILITY; SALMON;

ACRYLIC RESINS; ANIMALS; BONE DENSITY CONSERVATION AGENTS; CALCITONIN; DELAYED-ACTION PREPARATIONS; LACTIC ACID; MALE; NANOPARTICLES; POLYGLYCOLIC ACID; PROTEIN STABILITY; RATS; RATS, WISTAR; SALMON;

EID: 75449117868     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.3109/02652040902751125     Document Type: Article

References (31)

1. Aldini NN, Caliceti P, Lora S, Fini M, Giavaresi G, Roca M, et al.. 2001. Calcitonin release system in the treatment of experimental osteoporosis. Histomorphometric evaluation. J Orthop Res 19:955-961.
2. Blanco-Prieto MJ, Besseghir K, Orsolini P, Heimgartner F, Deuschel C, Merkle P, et al.. 1999. Importance of the test medium for the release kinetics of a somatostatin analogue from poly(D,L-lactide-co-glycolide) microspheres. Int J Pharm 184:243-250.
3. Blanco MD, Alonso M.J. 1997. Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres. Eur J Pharm Biopharm 43:287-294.
4. Body J-J. 2002. Calcitonin for the long-term prevention and treatment of postmenopausal osteoporosis. Bone 30:75S-79S.
5. Chernysheva Y, Babak VG, Kildeeva N, Boury F, Benoit JP, Ubrich N, et al.. 2003. Effect of the type of hydrophobic polymers on the size of nanoparticles obtained by emulsification-solvent evaporation. Mendeleev Comm 13:65-68.
6. Damgé C, Maincent P, Ubrich N. 2007. Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Contr Rel 117:163-170.
7. Dani BA, DeLuca PP. 2001. Preparation, characterization and in vivo evaluation of salmon calcitonin microspheres. AAPS PharmsciTech 2:22.
8. Diaz RV, Llabres M, Evora C. 1999. One-month sustained release microspheres of 125I-bovine calcitonin. In vitro-in vivo studies. J Contr Rel 59:55-62.
9. Dillen K, Vandervoort J, Van Den Mooter G, Ludwiga A. 2006. Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles. Int J Pharm 314:72-82.
10. Gao P, Ding P, Xu H, Yuan Z, Chen D, Wei J, et al.. 2006. In vitro and in vivo characterization of huperzine A loaded microspheres made from endgroup uncapped poly(D,L-lactide acid) and poly(D,L-lactide-co-glycolide acid). Chem Pharm Bull 54:89-93.
11. Gaudiano MC, Colone M, Bombelli C, Christolini P, Valvo L, Diociaiuti M. 2005. Early stages of salmon calcitonin aggregation: Effect induced by ageing and oxidation process in water and in the presence of model membranes. Biochim Biophys Acta 1750:134-145.
12. Gennari C. 2002. Analgesic effect of calcitonin in osteoporosis. Bone 30:67S-70S.
13. Hoffart V, Ubrich N, Simonin C, Babak V, Vigneron C, Hoffman M, et al.. 2002. Low molecular weight heparin-loaded polymeric nanoparticles: Formulation, characterization, and release characteristics. Drug Dev Ind Pharm 28:1091-1099.
14. Jiang G, Woo BH, Kang F, Singh J, DeLuca PP. 2002. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres. J Contr Rel 79:137-145.
15. Jiao YY, Ubrich N, Marchand-Arvier M, Vigneron C, Hoffman M, Maincent P. 2001. Preparation and in vitro evaluation of heparinloaded polymeric nanoparticles. Drug Deliv 8:135-141.
16. Johansen P, Corradin G, Merkle HP, Gander B. 1998. Release of tetanus toxoid from adjuvants and PLGA microspheres: How experimental set-up and surface adsorption fool the pattern. J Contr Rel 56:209-217.
17. Law SL, Shih CL. 1999. Adsorption of calcitonin to glass. Drug Dev Ind Pharm 25:253-256.
18. Lee KC, Lee YJ, Song HM, Chun CJ, DeLuca PP. 1992. Degradation of synthetic salmon calcitonin in aqueous solution. Pharm Res 9:1521-1523.
19. Lee KC, Soltis EE, Newman PS, Buron KW, Mehta RC, DeLuca PP. 1991. In vivo assessment of salmon calcitonin sustained release from biodegradable microspheres. J Contr Rel 17:199-206.
20. Lee YH, Sinko PJ. 2000. Oral delivery of salmon calcitonin. Adv Drug Deliv Rev 42:225-238.
21. Lucke A, Kiermaier J, Gopferich A. 2002. Peptide acylation by poly(alpha-hydroxy esters). Pharm Res 19:175-181.
22. Mehta RC, Thanoo BC, DeLuca PP. 1996. Peptide containing microspheres from low molecular weight and hydrophilic poly(D,L-lactideco-glycolide). J Contr Rel 41:249-257.
23. Munoz-Torres M, Alonso G, Raya MP. 2004. Calcitonin therapy in osteoporosis. Treat Endocrinol 3:117-132.
24. Reginster JY. 1995. Treatment of bone in elderly subjects: Calcium, vitamin D, fluor, bisphosphonates. Horm Res 43:83-88.
25. Sinko PJ, Smith CL, McWhorter LT, Stern W, Wagner E, Gilligan JP. 1995. Utility of pharmacodynamic measures for assessing the oral bioavailability of peptides. 1. Administration of recombinant salmon calcitonin in rats. J Pharm Sci 84:1374-1378.
26. Tasset Ch, Barette N, Thysman S, Ketelslegers JM, Lemoine D, Preat V. 1995. Polyisobutylcyanoacrylate nanoparticles as sustained release system for calcitonin. J Contr Rel 33:23-30.
27. Tsai T, Mehta RC, DeLuca PP. 1996. Adsorption of peptides to poly(D,L-lactide-co-glycolide): 2. Effect of solution properties on the adsorption. Int J Pharm 127:43-52. (Pubitemid 26069152)
28. Van Dijkhuizen-Radersma R, Nicolas HM, Van De Weert M, Blom M, De Groot K, Bezemer JM. 2002. Stability aspects of salmon calcitonin entrapped in poly(etherester) sustained release systems. Int J Pharm 248:229-237.
29. Yand J, Cleland JL. 1997. Factors affecting the in vitro release of recombinant human interferon-gamma (rgIFN-gamma) from PLGA microspheres. J Pharm Sci 86:908-914.
30. Zaidi M, Inzerillo AM, Moonga BS, Bevis PJR, Huang CL-H. 2002. Forty years of calcitonin-where are we now? A tribute to the work of Iain Macintyre, FRS. Bone 30:655-663.
31. Zolnik BS, Burgess DJ. 2007. Effect of acidic pH on PLGA microsphere degeneration and release. J Contr Rel 122:338-344.